相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1
Xiaolan Zhu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)
In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing
Simone Kreth et al.
ACTA NEUROPATHOLOGICA (2013)
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1
Jie Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
miR-153 Supports Colorectal Cancer Progression via Pleiotropic Effects That Enhance Invasion and Chemotherapeutic Resistance
Lei Zhang et al.
CANCER RESEARCH (2013)
Oncogenic miR-181a/b afect the DNA damage response in aggressive breast cancer
Andrea Bisso et al.
CELL CYCLE (2013)
Oncogenic effects of miR-10b in glioblastoma stem cells
Fadila Guessous et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
MicroRNA-153 is tumor suppressive in glioblastoma stem cells
Shiguang Zhao et al.
MOLECULAR BIOLOGY REPORTS (2013)
Molecular neuro-oncology in clinical practice: a new horizon
Michael Weller et al.
LANCET ONCOLOGY (2013)
Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO)
Annette Leibetseder et al.
NEURO-ONCOLOGY (2013)
MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells
Sandhya B. Rani et al.
NEURO-ONCOLOGY (2013)
MicroRNA-145 Is Downregulated in Glial Tumors and Regulates Glioma Cell Migration by Targeting Connective Tissue Growth Factor
Hae Kyung Lee et al.
PLOS ONE (2013)
Functional Profiling of Precursor MicroRNAs Identifies MicroRNAs Essential for Glioma Proliferation
Saija Haapa-Paananen et al.
PLOS ONE (2013)
CD133 Is Essential for Glioblastoma Stem Cell Maintenance
Paola Brescia et al.
STEM CELLS (2013)
MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1
Ariel Bier et al.
ONCOTARGET (2013)
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
Jessian L. Munoz et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells
Naohiro Nishida et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
The expression and function of microRNAs in chondrogenesis and osteoarthritis
Tracey E. Swingler et al.
ARTHRITIS AND RHEUMATISM (2012)
miR-181b Promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients
Baocan Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines
Sunwoo Koo et al.
BMC CANCER (2012)
MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer
Hiroshi Hirata et al.
CARCINOGENESIS (2012)
miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
Dan-Xia Zhu et al.
CARCINOGENESIS (2012)
The Promoter Hypermethylation Status of GATA6, MGMT, and FHIT in Glioblastoma
Gulsah Cecener et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Olea europaea leaf extract alters microRNA expression in human glioblastoma cells
Berrin Tunca et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells
Ming Shi et al.
JOURNAL OF PATHOLOGY (2012)
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Consolacion Melguizo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma
Wei-Yi Cheng et al.
PLOS ONE (2012)
BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
L. Persano et al.
CELL DEATH & DISEASE (2012)
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia
Rosa Visone et al.
BLOOD (2011)
ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*-Mediated Suppression of SOX2
Hye-Min Jeon et al.
CANCER RESEARCH (2011)
Let-7 microRNA inhibits the proliferation of human glioblastoma cells
Soon-Tae Lee et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells
Justin D. Lathia et al.
PLOS ONE (2011)
MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis
Atsushi Sato et al.
STEM CELLS (2011)
miR-195, miR-455-3p and miR-10a*are implicated in acquired temozolomide resistance in glioblastoma multiforme cells
Kenta Ujifuku et al.
CANCER LETTERS (2010)
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
Richard Hummel et al.
EUROPEAN JOURNAL OF CANCER (2010)
miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
Wei Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
B. Wang et al.
ONCOGENE (2010)
Interaction of Hypoxia-Inducible Factor-1α and Notch Signaling Regulates Medulloblastoma Precursor Proliferation and Fate
Francesca Pistollato et al.
STEM CELLS (2010)
Mir-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells
Ping Li et al.
JOURNAL OF BIOMEDICAL RESEARCH (2010)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
Sumihito Nobusawa et al.
CLINICAL CANCER RESEARCH (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas
Sibille Everhard et al.
NEURO-ONCOLOGY (2009)
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
Koichi Ichimura et al.
NEURO-ONCOLOGY (2009)
IFN-γ-mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation
Annabel F. Valledor et al.
BLOOD (2008)
hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells
Lei Shi et al.
BRAIN RESEARCH (2008)
Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas
David T. W. Jones et al.
CANCER RESEARCH (2008)
Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival
Judith N. Kloth et al.
MODERN PATHOLOGY (2008)
Brain Tumour Stem Cells: Implications for Cancer Therapy and Regenerative Medicine
Manuel Sanchez-Martin
CURRENT STEM CELL RESEARCH & THERAPY (2008)
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia
George A. Calin et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Expression of HOXC9 and E2F2 are up-regulated in CD133+cells isolated from human astrocytomas and associate with transformation of human astrocytes
Oswaldo K. Okamoto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Participation of an abnormality in the transforming growth factor-β signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor
Lei Zhang et al.
JOURNAL OF NEUROSURGERY (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival
W Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Brain tumor stem cells
PB Dirks
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Cancerous stem cells can arise from pediatric brain tumors
HD Hemmati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro
TN Ignatova et al.
GLIA (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
分享论文
